[go: up one dir, main page]

EP1633383A4 - Utilisation de l'erythropoietine pour un retablissement a la suite d'un accident ischemique cerebral - Google Patents

Utilisation de l'erythropoietine pour un retablissement a la suite d'un accident ischemique cerebral

Info

Publication number
EP1633383A4
EP1633383A4 EP04758471A EP04758471A EP1633383A4 EP 1633383 A4 EP1633383 A4 EP 1633383A4 EP 04758471 A EP04758471 A EP 04758471A EP 04758471 A EP04758471 A EP 04758471A EP 1633383 A4 EP1633383 A4 EP 1633383A4
Authority
EP
European Patent Office
Prior art keywords
erythropoietin
stroke recovery
stroke
recovery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04758471A
Other languages
German (de)
English (en)
Other versions
EP1633383A2 (fr
Inventor
Michael Gold
Michael J Renzi
Kenneth James Rhodes
Navneeth Thirumalai
Francis Farrell
Linda Jolliffe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of EP1633383A2 publication Critical patent/EP1633383A2/fr
Publication of EP1633383A4 publication Critical patent/EP1633383A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
EP04758471A 2003-03-27 2004-03-26 Utilisation de l'erythropoietine pour un retablissement a la suite d'un accident ischemique cerebral Withdrawn EP1633383A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45819303P 2003-03-27 2003-03-27
US47749403P 2003-06-11 2003-06-11
PCT/US2004/009443 WO2004087063A2 (fr) 2003-03-27 2004-03-26 Utilisation de l'erythropoietine pour un retablissement a la suite d'un accident ischemique cerebral

Publications (2)

Publication Number Publication Date
EP1633383A2 EP1633383A2 (fr) 2006-03-15
EP1633383A4 true EP1633383A4 (fr) 2008-05-21

Family

ID=33135092

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04758471A Withdrawn EP1633383A4 (fr) 2003-03-27 2004-03-26 Utilisation de l'erythropoietine pour un retablissement a la suite d'un accident ischemique cerebral

Country Status (11)

Country Link
US (1) US20040209812A1 (fr)
EP (1) EP1633383A4 (fr)
JP (1) JP2006521405A (fr)
AU (1) AU2004226372A1 (fr)
BR (1) BRPI0408829A (fr)
CA (1) CA2519803A1 (fr)
MX (1) MXPA05010345A (fr)
NO (1) NO20054976L (fr)
NZ (1) NZ542092A (fr)
RU (1) RU2341284C2 (fr)
WO (1) WO2004087063A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7345019B1 (en) * 1999-04-13 2008-03-18 The Kenneth S. Warren Institute, Inc. Modulation of excitable tissue function by peripherally administered erythropoietin
US20030072737A1 (en) 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
US7767643B2 (en) 2000-12-29 2010-08-03 The Kenneth S. Warren Institute, Inc. Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
WO2003018782A2 (fr) * 2001-08-30 2003-03-06 Stem Cell Therapeutics Inc. Regulation combinee de la production de cellules neurales
ATE541921T1 (de) * 2001-09-14 2012-02-15 Stem Cell Therapeutics Inc Prolaktin-induzierte zunahme an neuronalen stammzellen und dessen therapeutische anwendung
EP1430113A2 (fr) * 2001-09-18 2004-06-23 Stem Cell Therapeutics Inc. Effet de l'hormone de croissance et de l'igf-1 sur les cellules souches neuronales et leur application en therapeutique
CA2492442A1 (fr) * 2002-07-31 2004-02-05 Stem Cell Therapeutics Inc. Procede d'amelioration de la proliferation, de la differentiation et de la survie de cellules souches neurales au moyen du polypeptide d'activation d'adenylate cyclase hypophysaire (pacap)
JP2007505159A (ja) * 2003-05-19 2007-03-08 ザ ケネス エス．ウォーレン インスティテュート，インコーポレーテッド 延長された治療ウインドウを有する、応答性細胞、組織および器官の保護、回復および増強のための組織保護サイトカイン
ZA200603396B (en) * 2003-09-29 2007-11-28 Warren Pharmaceuticals Inc Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
WO2005077404A1 (fr) * 2004-02-13 2005-08-25 Stem Cell Therapeutics Corp. Utilisation de l'hormone de luteinisation (lh) et de la gonadotropine chorionique (hcg) pour la proliferation de cellules souches neuronales et la neurogenese
CN1897960A (zh) * 2004-05-20 2007-01-17 肯尼思S.沃伦协会有限公司 用于保护、恢复和增强效应细胞、组织和器官具有延迟的治疗窗口的组织保护性细胞因子
EP1928488A4 (fr) 2005-09-27 2009-07-22 Stem Cell Therapeutics Corp Regulation par la prolactine de la proliferation des cellules precurseurs d'oligodendrocytes
CA2643502A1 (fr) * 2006-03-17 2007-09-27 Stem Cell Therapeutics Corp. Regimes de dosage de lh ou hcg et epo pour le traitement de troubles neurologiques
NZ573792A (en) * 2006-06-07 2011-09-30 Univ Tokushima Treatment of ischemic disease using erythropoietin mobilised mononuclear cells
CA2977823A1 (fr) 2008-11-25 2010-06-03 Otsuka Pharmaceutical Co., Ltd. Cellule souche d'utilisation therapeutique qui est issue de monocyte humain et son procede d'induction
RU2495688C1 (ru) * 2012-03-28 2013-10-20 Государственное бюджетное учреждение здравоохранения Центр организации специализированной медицинской помощи "Челябинский государственный институт лазерной хирургии" Способ лечения ишемии головного мозга в эксперименте
RU2496513C1 (ru) * 2012-09-27 2013-10-27 Государственное бюджетное учреждение здравоохранения Центр организации специализированной медицинской помощи "Челябинский государственный институт лазерной хирургии" Способ лечения ишемии спинного мозга в эксперименте

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035475A2 (fr) * 1998-12-14 2000-06-22 Hannelore Ehrenreich Methode de traitement des ischemies cerebrales et utilisation de l'erythropoietine ou de derives de l'erythropoietine pour traiter les ischemies cerebrales
WO2000061164A1 (fr) * 1999-04-13 2000-10-19 Kenneth S. Warren Laboratories Modulation de la fonction d'un tissu excitable par administration peripherique d'une erythropoietine
WO2003037273A2 (fr) * 2001-11-01 2003-05-08 University Of Utah Research Foundation Methode d'utilisation de l'erythropoietine pour traiter l'insuffisance renale ischemique aigue
WO2004112693A2 (fr) * 2003-05-19 2004-12-29 The Kenneth S. Warren Institute, Inc. Cytokines de protection tissulaire pour la protection, la restauration, et l'amelioration de cellules, tissus et organes sensibles avec une fenetre therapeutique etendue

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE520730C2 (sv) * 1995-01-20 2003-08-19 Eskil Elmer Behandling av hjärnischemi och hjärnskador med ett neuroprotektivt läkemedel
US6121246A (en) * 1995-10-20 2000-09-19 St. Elizabeth's Medical Center Of Boston, Inc. Method for treating ischemic tissue
US6165783A (en) * 1997-10-24 2000-12-26 Neuro Spheres Holdings Ltd. Erythropoietin-mediated neurogenesis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035475A2 (fr) * 1998-12-14 2000-06-22 Hannelore Ehrenreich Methode de traitement des ischemies cerebrales et utilisation de l'erythropoietine ou de derives de l'erythropoietine pour traiter les ischemies cerebrales
WO2000061164A1 (fr) * 1999-04-13 2000-10-19 Kenneth S. Warren Laboratories Modulation de la fonction d'un tissu excitable par administration peripherique d'une erythropoietine
WO2003037273A2 (fr) * 2001-11-01 2003-05-08 University Of Utah Research Foundation Methode d'utilisation de l'erythropoietine pour traiter l'insuffisance renale ischemique aigue
WO2004112693A2 (fr) * 2003-05-19 2004-12-29 The Kenneth S. Warren Institute, Inc. Cytokines de protection tissulaire pour la protection, la restauration, et l'amelioration de cellules, tissus et organes sensibles avec une fenetre therapeutique etendue

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EHRENREICH HANNELORE ET AL: "Erythropoietin therapy for acute stroke is both safe and beneficial.", MOLECULAR MEDICINE (CAMBRIDGE, MASS.) AUG 2002, vol. 8, no. 8, August 2002 (2002-08-01), pages 495 - 505, XP009098629, ISSN: 1076-1551 *

Also Published As

Publication number Publication date
WO2004087063A3 (fr) 2005-05-19
US20040209812A1 (en) 2004-10-21
AU2004226372A1 (en) 2004-10-14
BRPI0408829A (pt) 2006-04-04
WO2004087063A2 (fr) 2004-10-14
MXPA05010345A (es) 2006-03-08
NZ542092A (en) 2008-04-30
CA2519803A1 (fr) 2004-10-14
RU2341284C2 (ru) 2008-12-20
RU2005130023A (ru) 2006-03-20
NO20054976L (no) 2005-10-26
JP2006521405A (ja) 2006-09-21
EP1633383A2 (fr) 2006-03-15

Similar Documents

Publication Publication Date Title
AU154856S (en) Pen
EP1633383A4 (fr) Utilisation de l'erythropoietine pour un retablissement a la suite d'un accident ischemique cerebral
GB0320973D0 (en) Improvements in or relating to similarity measures
TW567963U (en) Versatile use pliers
GB0317615D0 (en) Improvements in or relating to stairlifts
DE602004010410D1 (en) Polymorphe form von 3-phenylsulfonyl-8-piperazin-1-yl-chinolin
IL175154A0 (en) Novel salicytic anilides
GB0317618D0 (en) Improvements in or relating to stairlifts
GB0311208D0 (en) Feature based caricaturing
GB0306367D0 (en) Improvements in or relating to stairlifts
GB0407556D0 (en) Improvements in or relating to photodection
GB0302741D0 (en) Use
GB2409446B (en) Improvements in or relating to stairlifts
GB0313913D0 (en) New use
GB2399859B (en) Stay
HK1087631A (en) Use of erythropoietin in stroke recovery
GB0326454D0 (en) Magik top
GB0320627D0 (en) Methods
AU155550S (en) Pen
GB0316757D0 (en) Use
GB0327619D0 (en) New use
TWM350558U (en) Texturierduse zum texturieren von endlosgarn
GB0305252D0 (en) Methods
GB0316358D0 (en) New uses
AU3371P (en) Mandelup Lupinus augustifolius

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051021

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1087631

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20080422

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 9/10 20060101ALI20080416BHEP

Ipc: C07K 14/505 20060101ALI20080416BHEP

Ipc: A61K 38/00 20060101AFI20050603BHEP

17Q First examination report despatched

Effective date: 20080729

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090210

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1087631

Country of ref document: HK